Published on: October 6, 2014

Finding the Right Doctor for Your Hip Revision Surgery

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Revision surgeries for patients who received Stryker Rejuvenate hip implants are much more complex and difficult than people believe them to be. For this reason, many surgeons and doctors are cautious about recommending or performing the procedures due to the significant risks associated with them.

Each patient’s age, existing medical conditions and the complications that they are experiencing due to the defective device are all considered, but doctors typically consider revision surgery to be a last resort measure— only to be performed if the patient is suffering severe complications or at an elevated risk of life-threatening conditions.

Published on: August 18, 2014

Death During or Following Hip Revision Surgery

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Patients Dying During A Hip Revision Procedure

Every year, thousands of individuals suffering from limited mobility undergo hip replacement surgery to improve the quality of their life and eliminate pain in their hip. Unfortunately, not every hip replacement surgery is successful. Often times, significant issues arise where there is an immediate need for revision surgery. The existing device is replaced with a secondary implant after a lengthy and complex procedure. Unfortunately, some patients die during the hip revision surgery as a result of complications, or in the months or years that follow.

Published on: August 11, 2014

Stryker Hip Revision Surgery: Deep Vein Thrombosis (DVT) Related Issues

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Postoperative deep vein thrombosis (DVT) can be a significant problem after a Stryker hip revision surgery, leading to lethal complications. Many times, DVT is challenging to diagnose because classic clinical symptoms and signs are not always present. If the doctor is not suspicious or curious of obvious lacking signs, the individual can develop significantly serious problems, which could lead to death.

In 2009, the Stryker orthopedic medical device company began marketing its Rejuvenate and ABG II modular hip replacement systems. Originally, the hip implants were thought to be far superior to traditional metal-on-metal hip replacement devices. Unfortunately, by July 2012, Stryker voluntarily recalled their hip replacement systems due to significant issues including injury and death related to DVT and other medical problems.

Published on: July 28, 2014

Infections Associated With Femur Fractures When A Stryker Device Is Removed

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

An infection caused by a femur fracture is one of the leading devastating complications resulting in hip revision surgery. A periprosthetic fracture on the patient’s femur can occur by accident during revision surgery when attempting to remove the implant for replacement. However, the surgeon often has no other alternative but to purposely fracture the patient’s femur during surgery to remove the implant stem.

An infection within the hip joint and/or stem often leads to the need for revision surgery as a correction for numerous reasons, which might include:

Published on: April 21, 2014

What to Expect Before & After a Stryker Hip Revision Surgery

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Expectations prior and post hip revision surgery Patients who experience a corrosion of components in Stryker hip implants may need to receive a revision surgery. As Stryker components become worn, they can release metal debris into the bloodstream. The release of metal debris can then trigger conditions like metallosis (see here) and adverse tissue reaction. If patients experience pain and swelling, these can be indicators of adverse tissue reaction. Patients who have these symptoms should speak with a physician about their options and whether they may require a revision surgery.

Diagnosing Issues Related to Stryker Hip Implants

Published on: July 25, 2013

Demographics Of People Requiring A Stryker Hip Revision Surgery. Who Are They?

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Adverse Local Tissue Reaction in Hip Revision Surgery Patients

A recent research study completed by H. John Cooper and his associates revealed that individuals between the ages of 43 to 77 were at risk for developing metal poisoning and significant on-set pain after a revision surgery involving metal hip replacement devices. The study is entitled, “Adverse Local Tissue Reaction Arising from Corrosion at the Femoral Neck-Body Junction in a Dual-Taper Stem with a Cobalt-Chromium Modular Neck” and has been published by the Journal of Bone and Joint Surgery.

Published on: July 18, 2013

Metal Poisoning In Stryker Hip Patients: Significance Of Cobalt, Chromium & Titanium Levels

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

The Risk of Metal Poisoning in Stryker Hip Patients: Development of High Cobalt Levels

In an unsettling report recently published in the Journal of Bone and Joint Surgery, medical researchers discovered that disproportionate levels of cobalt placed Stryker hip patients at a severe risk of developing harmful disorders like metal poisoning. The research study was conducted by H. John Cooper and his associates at the Rush University Medical Center, Northwestern University Feinberg School of Medicine and Indiana University School of Medicine.

Published on: April 4, 2013

Consolidation Of Stryker Lawsuit Cases

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Stryker Corporation, makers of the Stryker Rejuvenate and ABG II hip replacements that were recalled in 2012, is the next company to be part of multi district litigation (MDL) for the lawsuits related to their hip recall. The New Jersey Superior Court considered the application for MDL in January 2013 and then began forming the committees and pre-trial stipulations to consolidate the recall cases in Bergen County, NJ. This is following in the footsteps of the DePuy recall, which is also a MDL in Bergen County.

How Does MDL Work?

Published on: April 2, 2013

Did Stryker Delay in Recalling Its Hip Implants?

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Stryker’s hip implants, the Stryker Rejuvenate, and the ABG II, are supposed to last between 15 and 20 years. Instead, many patients are finding that they’re having problems after just two years– or less of service. In fact, some patients are experiencing pain, dislocation and other complications just weeks after the surgery.

Stryker’s first hip implant, the Stryker Rejuvenate, was first distributed in February 2010. They issued their recall on July 6, 2012.

Published on: March 20, 2013

When And What Did DePuy Know About The Dangerous Defects With Their Hips?

by Drug Law Center

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

As the over 10,000 pending civil cases await trial, the question that is being asked in litigation preparation is exactly when Johnson & Johnson’s DePuy division found out that there were defects in their product and what information did they conceal from the public? The first case has already been tried and resulted in an $8.3 million verdict for the plaintiff. The second case is already underway in state court in Chicago, IL and many more are to come that will debate the same question in front of a jury.

Metal-On-Metal Hip Implant Problems